IL48423A - (4-acylpiperazin-1-yl)carbonyloxyisoindolinones,5h-pyrrolo(3,4-b)pyrazines, 5h-1,4-oxathiano(2,3-c) pyrroles, their preparation and pharmaceutical compositions containing thesame - Google Patents

(4-acylpiperazin-1-yl)carbonyloxyisoindolinones,5h-pyrrolo(3,4-b)pyrazines, 5h-1,4-oxathiano(2,3-c) pyrroles, their preparation and pharmaceutical compositions containing thesame

Info

Publication number
IL48423A
IL48423A IL48423A IL4842375A IL48423A IL 48423 A IL48423 A IL 48423A IL 48423 A IL48423 A IL 48423A IL 4842375 A IL4842375 A IL 4842375A IL 48423 A IL48423 A IL 48423A
Authority
IL
Israel
Prior art keywords
oxathiano
carbonyloxyisoindolinones
acylpiperazin
pyrazines
pyrroles
Prior art date
Application number
IL48423A
Other languages
English (en)
Other versions
IL48423A0 (en
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7436963A external-priority patent/FR2313060A1/fr
Priority claimed from FR7527160A external-priority patent/FR2322600A1/fr
Priority claimed from FR7527162A external-priority patent/FR2322602A1/fr
Priority claimed from FR7527161A external-priority patent/FR2322601A1/fr
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of IL48423A0 publication Critical patent/IL48423A0/xx
Publication of IL48423A publication Critical patent/IL48423A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL48423A 1974-11-07 1975-11-05 (4-acylpiperazin-1-yl)carbonyloxyisoindolinones,5h-pyrrolo(3,4-b)pyrazines, 5h-1,4-oxathiano(2,3-c) pyrroles, their preparation and pharmaceutical compositions containing thesame IL48423A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7436963A FR2313060A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527160A FR2322600A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de la pyrrolo (3,4-b) pyrazine, leur preparation et les compositions qui les contiennent
FR7527162A FR2322602A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'oxathiinno- et du dithiinnopyrrole, leur preparation et les compositions qui les contiennent
FR7527161A FR2322601A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
IL48423A0 IL48423A0 (en) 1976-01-30
IL48423A true IL48423A (en) 1979-03-12

Family

ID=27446274

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48423A IL48423A (en) 1974-11-07 1975-11-05 (4-acylpiperazin-1-yl)carbonyloxyisoindolinones,5h-pyrrolo(3,4-b)pyrazines, 5h-1,4-oxathiano(2,3-c) pyrroles, their preparation and pharmaceutical compositions containing thesame

Country Status (27)

Country Link
US (1) US4220646A (de)
JP (2) JPS5422996B2 (de)
AR (2) AR208414A1 (de)
AT (2) AT343123B (de)
AU (1) AU503200B2 (de)
BE (1) BE835325A (de)
CA (1) CA1057755A (de)
CH (1) CH609057A5 (de)
CS (2) CS231957B2 (de)
CY (1) CY1045A (de)
DD (1) DD122684A5 (de)
DE (1) DE2550111C2 (de)
DK (1) DK141098B (de)
FI (1) FI60707C (de)
GB (1) GB1468497A (de)
HK (1) HK19380A (de)
HU (1) HU173108B (de)
IE (1) IE41928B1 (de)
IL (1) IL48423A (de)
LU (1) LU73738A1 (de)
NL (1) NL177405C (de)
NO (1) NO143576C (de)
OA (1) OA05162A (de)
PL (1) PL101248B1 (de)
SE (1) SE407063B (de)
SU (2) SU673173A3 (de)
YU (2) YU39583B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371198A2 (fr) * 1976-11-22 1978-06-16 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
US4533751A (en) * 1981-10-09 1985-08-06 Scm Corporation Preparation of 1,3-dienamines from myrcene and substituted myrcene
FR2525606A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiino (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US5786357A (en) * 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5565567A (en) * 1993-06-04 1996-10-15 Henkel Corporation. Polymerizable N,N'-substituted piperazine acrylamide compounds
US5922820A (en) * 1993-06-04 1999-07-13 Henkel Corporation Polymerizable compounds
EP0723542A4 (de) * 1993-06-04 1996-10-23 Henkel Corp Polymerisierbare verbindungen
WO1996009297A1 (en) 1994-09-23 1996-03-28 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell inflammatory condition
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5756742A (en) * 1995-12-22 1998-05-26 Henkel Corporation Polymerizable compounds
US6339086B1 (en) 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
US7902179B2 (en) * 2001-04-26 2011-03-08 Ajinomoto Co., Inc. Heterocyclic compounds
DK1490363T3 (da) * 2002-03-29 2006-05-15 Indevus Pharmaceuticals Inc Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon
WO2004037212A2 (en) * 2002-10-24 2004-05-06 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
AR042194A1 (es) * 2002-11-22 2005-06-15 Merck & Co Inc Metodo para preparar inhibidores de fosfodiesterasa - 4
UA79518C2 (en) * 2002-11-22 2007-06-25 Merck & Co Inc Process for preparation of phosphodiesterase-4 inhibitors
US6909002B2 (en) * 2002-11-22 2005-06-21 Merck & Co., Inc. Method of preparing inhibitors of phosphodiesterase-4
EP1691811B1 (de) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Kombination aus einem sedativum und einem neurotransmitter-modulator und verfahren zur verbesserung der schlafqualität und zur behandlung von depression
WO2005105061A2 (en) * 2004-04-14 2005-11-10 Indevus Pharmaceuticals, Inc. Transdermal patch
EP1904066B1 (de) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. KOMBINATIONEN VON ESZOPICLON UND TRANS-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS-4-(3,4-DICHLORPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALINAMIN ZUR BEHANDLUNG DER MENOPAUSE, Perimenopause UND VON KOGNITIVEN STÖRUNGEN
EP1904046A4 (de) * 2005-07-06 2008-10-01 Sepracor Inc Kombinationen von eszopiclon und o-desmethylvenlafaxin und verfahren zur behandlung der menopause und von stimmungsschwankungen; angstzuständen und kognitiven störungen
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2377531A2 (de) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
CN100569775C (zh) * 2007-12-19 2009-12-16 齐鲁天和惠世制药有限公司 佐匹克隆的晶型转换的方法
WO2010088385A1 (en) 2009-01-30 2010-08-05 Sepracor Inc. Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US11820912B2 (en) * 2017-05-25 2023-11-21 Shin-Etsu Chemical Co., Ltd. Fluoropolyether group-containing polymer-modified organic silicon compound, surface treatment agent, and article
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR2101081B1 (de) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
BE790408A (fr) * 1971-10-22 1973-04-20 Rhone Poulenc Sa Nouveaux derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
BE793851A (fr) * 1972-01-10 1973-07-10 Rhone Poulenc Sa Nouveaux derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.

Also Published As

Publication number Publication date
SU604496A3 (ru) 1978-04-25
YU192182A (en) 1983-01-21
ATA848675A (de) 1977-09-15
CA1057755A (fr) 1979-07-03
JPS5498790A (en) 1979-08-03
GB1468497A (en) 1977-03-30
DK141098C (de) 1980-07-07
JPS5422996B2 (de) 1979-08-10
DE2550111C2 (de) 1983-09-15
NO143576C (no) 1981-03-11
AU503200B2 (en) 1979-08-30
AU8633175A (en) 1977-05-12
DK499275A (de) 1976-05-08
JPS558508B2 (de) 1980-03-04
BE835325A (fr) 1976-05-06
HU173108B (hu) 1979-02-28
ATA401977A (de) 1977-10-15
YU281575A (en) 1983-01-21
AT343666B (de) 1978-06-12
DE2550111A1 (de) 1976-05-13
IL48423A0 (en) 1976-01-30
NL177405C (nl) 1985-09-16
CS598377A2 (en) 1984-01-16
CH609057A5 (de) 1979-02-15
JPS5170776A (de) 1976-06-18
PL101248B1 (pl) 1978-12-30
FI60707B (fi) 1981-11-30
CY1045A (en) 1980-08-01
NO753713L (de) 1976-05-10
CS231957B2 (en) 1985-01-16
CS231958B2 (en) 1985-01-16
AT343123B (de) 1978-05-10
SE7512477L (sv) 1976-05-10
DK141098B (da) 1980-01-14
OA05162A (fr) 1981-01-31
HK19380A (en) 1980-04-18
LU73738A1 (de) 1976-09-06
DD122684A5 (de) 1976-10-20
FI60707C (fi) 1982-03-10
SE407063B (sv) 1979-03-12
AR208800A1 (es) 1977-02-28
NL7512732A (nl) 1976-05-11
IE41928B1 (en) 1980-04-23
FI753127A (de) 1976-05-08
CS751075A2 (en) 1984-01-16
US4220646A (en) 1980-09-02
NO143576B (no) 1980-12-01
YU40087B (en) 1985-06-30
YU39583B (en) 1985-03-20
NL177405B (nl) 1985-04-16
AR208414A1 (es) 1976-12-27
IE41928L (en) 1976-05-07
SU673173A3 (ru) 1979-07-05

Similar Documents

Publication Publication Date Title
IL48423A (en) (4-acylpiperazin-1-yl)carbonyloxyisoindolinones,5h-pyrrolo(3,4-b)pyrazines, 5h-1,4-oxathiano(2,3-c) pyrroles, their preparation and pharmaceutical compositions containing thesame
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL48069A (en) Imidazo-(1,5-a)(1,4)-diazepine derivatives, their preparation and pharmaceutical compositions containing them
IL56078A (en) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidin-4-one derivatives,their preparation and pharmaceutical compositions containing them
IL54519A0 (en) 2-diarylalkyl-1-azabicyclo (2,2,2) octanes, their preparation and pharmaceutical compositions containing them
IL52997A0 (en) New 1h-pyrazolo(3,4-b)pyridine derivatives their preparation and pharmaceutical compositions containing them
IL50208A0 (en) Triazolo (3,4-b) isoquinoline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL50930A (en) 1-alkyl-4-oxo-1,6,7,8-tetrahydro-4h-pyrido(1,2-a)pyrimidine-3-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
IL48502A (en) Tthieno(1,5)benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL54813A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL54814A0 (en) Novel pyrido(2,3-b) (1,4) benzodiazepine derivatives, their preparation and pharmaceutical compositions containing tthem
IL50816A (en) 6-aryl-s-triazolo(4,3-a)-(or tetrazolo(1,5-a)pyrido(2,3-f)-diazepines, their preparation and pharmaceutical compositions containing them
IL44127A0 (en) Imidazo(4,5-b)pyridines,their preparation and pharmaceutical compositions containing them
IL52857A0 (en) Novel benzopyrane derivatives their preparation and pharmaceutical compositions containing them
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL51853A (en) 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
IL55134A0 (en) Novel benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
IL46864A0 (en) New pyrimido(1,2-a)quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL44895A (en) 3h-thiazolo(4,3-a)isoquinolines and 2h-isohtiazolo(3,2-a)isoquinolines their preparation and pharmaceutical compositions containing them
IL49368A0 (en) 4,5,6,7-tetrahydro-thieno(3,2-c)-pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL40800A0 (en) Thiazolo(5,4-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IL48192A0 (en) 4-oxo-4h-pyrano(3,2-c)quinoline derivatives,their preparation and pharmaceutical compositions containing them